By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cynvenio Biosystems, Inc. 

2260 Townsgate Road
Unit 2
Westlake Village  California  91361  U.S.A.
Phone: 805-777-0017 Fax: 508-464-8538


Company News
Cynvenio Releases Second-Generation ClearID Breast Cancer Blood Test 1/9/2017 11:01:03 AM
Cynvenio Clinical Trial Data Supports Benefits Of Multi-Template Liquid Biopsy Sequencing For Cancer Mutational Profiling 4/5/2016 10:38:34 AM
Cynvenio Honors Triple Negative Breast Cancer Day With Clinical Trial Launch And Event At Pink Lotus Breast Center In Los Angeles 3/3/2016 10:53:34 AM
Cynvenio Announces Availability Of Concordia, A New Cell-Free DNA Purification Upgrade For Its LiquidBiopsy Whole Blood Enrichment Platform 2/10/2016 10:42:45 AM
Cynvenio And Atgen Open Recruitment For New Liquidbiopsy Clinical Research Study In Triple Negative Breast Cancer 12/28/2015 9:40:08 AM
Cynvenio Announces New PD-L1 Test For Tumor Cells In Blood 10/1/2015 11:27:26 AM
Cynvenio And ATGen Announce Strategic Partnership To Bring NK Vue Natural Killer Cell Test To US Market 9/28/2015 1:04:37 PM
Cynvenio Receives Accreditation From College of American Pathologists 9/8/2015 11:39:42 AM
Cynvenio Appoints Leading Oncologist And Seasoned Medical Executive Paul Y. Song, M.D., As Chief Medical Officer 9/4/2015 7:21:13 AM
Week In Review: Livzon Leads $26 Million Funding Of Cynvenio 6/22/2015 9:06:28 AM